These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 19839062

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Two pathways for tBID-induced cytochrome c release from rat brain mitochondria: BAK- versus BAX-dependence.
    Brustovetsky N, Dubinsky JM, Antonsson B, Jemmerson R.
    J Neurochem; 2003 Jan; 84(1):196-207. PubMed ID: 12485416
    [Abstract] [Full Text] [Related]

  • 26. Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2/Bcl-xL inhibitor, ABT-737.
    Okumura K, Huang S, Sinicrope FA.
    Clin Cancer Res; 2008 Dec 15; 14(24):8132-42. PubMed ID: 19088028
    [Abstract] [Full Text] [Related]

  • 27. ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells.
    Cristofanon S, Fulda S.
    Cell Death Dis; 2012 Nov 29; 3(11):e432. PubMed ID: 23190604
    [Abstract] [Full Text] [Related]

  • 28. Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1.
    Croker BA, O'Donnell JA, Nowell CJ, Metcalf D, Dewson G, Campbell KJ, Rogers KL, Hu Y, Smyth GK, Zhang JG, White M, Lackovic K, Cengia LH, O'Reilly LA, Bouillet P, Cory S, Strasser A, Roberts AW.
    Proc Natl Acad Sci U S A; 2011 Aug 09; 108(32):13135-40. PubMed ID: 21768356
    [Abstract] [Full Text] [Related]

  • 29. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies.
    Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH.
    Nat Cell Biol; 2006 Dec 09; 8(12):1348-58. PubMed ID: 17115033
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Diffuse large B-cell lymphomas with germinal center B-cell-like differentiation immunophenotypic profile are associated with high apoptotic index, high expression of the proapoptotic proteins bax, bak and bid and low expression of the antiapoptotic protein bcl-xl.
    Bai M, Skyrlas A, Agnantis NJ, Kamina S, Tsanou E, Grepi C, Galani V, Kanavaros P.
    Mod Pathol; 2004 Jul 09; 17(7):847-56. PubMed ID: 15073604
    [Abstract] [Full Text] [Related]

  • 34. Mcl-1 and Bcl-xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver.
    Hikita H, Takehara T, Shimizu S, Kodama T, Li W, Miyagi T, Hosui A, Ishida H, Ohkawa K, Kanto T, Hiramatsu N, Yin XM, Hennighausen L, Tatsumi T, Hayashi N.
    Hepatology; 2009 Oct 09; 50(4):1217-26. PubMed ID: 19676108
    [Abstract] [Full Text] [Related]

  • 35. Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization.
    Buron N, Porceddu M, Brabant M, Desgué D, Racoeur C, Lassalle M, Péchoux C, Rustin P, Jacotot E, Borgne-Sanchez A.
    PLoS One; 2010 Mar 31; 5(3):e9924. PubMed ID: 20360986
    [Abstract] [Full Text] [Related]

  • 36. Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
    Park D, Magis AT, Li R, Owonikoko TK, Sica GL, Sun SY, Ramalingam SS, Khuri FR, Curran WJ, Deng X.
    Cancer Res; 2013 Sep 01; 73(17):5485-96. PubMed ID: 23824742
    [Abstract] [Full Text] [Related]

  • 37. Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B.
    Rooswinkel RW, van de Kooij B, Verheij M, Borst J.
    Cell Death Dis; 2012 Aug 09; 3(8):e366. PubMed ID: 22875003
    [Abstract] [Full Text] [Related]

  • 38. Co-administration of the mTORC1/TORC2 inhibitor INK128 and the Bcl-2/Bcl-xL antagonist ABT-737 kills human myeloid leukemia cells through Mcl-1 down-regulation and AKT inactivation.
    Rahmani M, Aust MM, Hawkins E, Parker RE, Ross M, Kmieciak M, Reshko LB, Rizzo KA, Dumur CI, Ferreira-Gonzalez A, Grant S.
    Haematologica; 2015 Dec 09; 100(12):1553-63. PubMed ID: 26452980
    [Abstract] [Full Text] [Related]

  • 39. Cleavage by Caspase 8 and Mitochondrial Membrane Association Activate the BH3-only Protein Bid during TRAIL-induced Apoptosis.
    Huang K, Zhang J, O'Neill KL, Gurumurthy CB, Quadros RM, Tu Y, Luo X.
    J Biol Chem; 2016 May 27; 291(22):11843-51. PubMed ID: 27053107
    [Abstract] [Full Text] [Related]

  • 40. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist.
    Simmons MJ, Fan G, Zong WX, Degenhardt K, White E, Gélinas C.
    Oncogene; 2008 Feb 28; 27(10):1421-8. PubMed ID: 17724464
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.